BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu X, Wang S, Wang X, Liang J, Zhang Y. Recent drug therapies for corneal neovascularization. Chem Biol Drug Des 2017;90:653-64. [DOI: 10.1111/cbdd.13018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Yin Y, Zhao J, Li Y, Wang Y, Zhang Z, Niu L, Zheng Y. An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization. Int J Nanomedicine 2022;17:4911-31. [PMID: 36267540 DOI: 10.2147/IJN.S375570] [Reference Citation Analysis]
2 Huang W, Wang L, Yang R, Hu R, Zheng Q, Zan X. Combined delivery of small molecule and protein drugs as synergistic therapeutics for treating corneal neovascularization by a one-pot coassembly strategy. Mater Today Bio 2022;17:100456. [PMID: 36281304 DOI: 10.1016/j.mtbio.2022.100456] [Reference Citation Analysis]
3 Zhu H, Yu J, Ye J, Wu Y, Pan J, Li Y, Chen C, Zheng L, Liu G, Chu C. Nanoparticle-mediated corneal neovascularization treatments: Toward new generation of drug delivery systems. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.06.071] [Reference Citation Analysis]
4 Liu A, Liang C, Liu J, Huang Y, Wang M, Wang L. Reactive Oxygen Species─Responsive Lipid Nanoparticles for Effective RNAi and Corneal Neovascularization Therapy. ACS Appl Mater Interfaces 2022;14:17022-31. [PMID: 35380773 DOI: 10.1021/acsami.1c23412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Chen J, Ding X, Du W, Tang X, Yu WZ. Inhibition of corneal neovascularization by topical application of nintedanib in rabbit models. Int J Ophthalmol 2021;14:1666-73. [PMID: 34804855 DOI: 10.18240/ijo.2021.11.04] [Reference Citation Analysis]
6 Yan D, Yu F, Chen L, Yao Q, Yan C, Zhang S, Wu N, Gong D, Sun H, Fu Y, Shao C. Subconjunctival Injection of Regulatory T Cells Potentiates Corneal Healing Via Orchestrating Inflammation and Tissue Repair After Acute Alkali Burn. Invest Ophthalmol Vis Sci 2020;61:22. [PMID: 33326018 DOI: 10.1167/iovs.61.14.22] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Balne PK, Gupta S, Zhang J, Bristow D, Faubion M, Heil SD, Sinha PR, Green SL, Iozzo RV, Mohan RR. The functional role of decorin in corneal neovascularization in vivo. Exp Eye Res 2021;207:108610. [PMID: 33940009 DOI: 10.1016/j.exer.2021.108610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yu J, Chu C, Wu Y, Liu G, Li W. The phototherapy toward corneal neovascularization elimination: An efficient, selective and safe strategy. Chinese Chemical Letters 2021;32:99-101. [DOI: 10.1016/j.cclet.2020.11.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chen F, Si P, de la Zerda A, Jokerst JV, Myung D. Gold nanoparticles to enhance ophthalmic imaging. Biomater Sci 2021;9:367-90. [PMID: 33057463 DOI: 10.1039/d0bm01063d] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
10 Chu C, Yu J, Ren E, Ou S, Zhang Y, Wu Y, Wu H, Zhang Y, Zhu J, Dai Q, Wang X, Zhao Q, Li W, Liu Z, Chen X, Liu G. Multimodal Photoacoustic Imaging-Guided Regression of Corneal Neovascularization: A Non-Invasive and Safe Strategy. Adv Sci (Weinh) 2020;7:2000346. [PMID: 32714751 DOI: 10.1002/advs.202000346] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
11 Shu-Ya T, Qiu-Yang Z, Jing-Jing L, Jin Y, Biao Y. Suppression of pathological ocular neovascularization by a small molecule, SU1498. Biomed Pharmacother 2020;128:110248. [PMID: 32454287 DOI: 10.1016/j.biopha.2020.110248] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Zhang J, Wang S, He Y, Yao B, Zhang Y. Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization. Chem Biol Drug Des 2020;95:485-92. [PMID: 31002472 DOI: 10.1111/cbdd.13529] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
13 Cissé Y, Bai L, Chen MT. LncRNAs in ocular neovascularizations. Int J Ophthalmol 2019;12:1959-65. [PMID: 31850182 DOI: 10.18240/ijo.2019.12.19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Türker E, Garreis F, Khajavi N, Reinach PS, Joshi P, Brockmann T, Lucius A, Ljubojevic N, Turan E, Cooper D, Schick F, Reinholz R, Pleyer U, Köhrle J, Mergler S. Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T1AM) in Human Corneal Keratocytes. Front Endocrinol (Lausanne) 2018;9:670. [PMID: 30524369 DOI: 10.3389/fendo.2018.00670] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
15 Türker E, Garreis F, Khajavi N, Reinach PS, Joshi P, Brockmann T, Lucius A, Ljubojevic N, Turan E, Cooper D, Schick F, Reinholz R, Pleyer U, Köhrle J, Mergler S. Vascular Endothelial Growth Factor (VEGF) Induced Downstream Responses to Transient Receptor Potential Vanilloid 1 (TRPV1) and 3-Iodothyronamine (3-T1AM) in Human Corneal Keratocytes. Front Endocrinol 2018;9:670. [DOI: 10.3389/fendo.2018.00670] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Torrecilla J, Del Pozo-Rodríguez A, Vicente-Pascual M, Solinís MÁ, Rodríguez-Gascón A. Targeting corneal inflammation by gene therapy: Emerging strategies for keratitis. Exp Eye Res 2018;176:130-40. [PMID: 29981344 DOI: 10.1016/j.exer.2018.07.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
17 Roshandel D, Eslani M, Baradaran-Rafii A, Cheung AY, Kurji K, Jabbehdari S, Maiz A, Jalali S, Djalilian AR, Holland EJ. Current and emerging therapies for corneal neovascularization. Ocul Surf 2018;16:398-414. [PMID: 29908870 DOI: 10.1016/j.jtos.2018.06.004] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 13.6] [Reference Citation Analysis]